Friday, July 10, 2026

pharma · Moderate to Severe Platysma Prominence · Chronic migraine

Merz Therapeutics

Merz Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

frankfurt am main, DE HQ
2020 Founded
1,312 Employees
EMA registrant Type
Company details
Status
Public
HQ
frankfurt am main, DE
Founded
2020
Employees
1,312
Programs
3
Drugs
5
Patents
0
Intelligence · Clinical Trials

Merz Therapeutics clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Merz Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Merz Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Merz Therapeutics.

  1. NT-PPR-EU002 — Phase 3

    Clinical update
  2. M602011085 — Phase 3

    Clinical update
  3. M602011084 — Phase 3

    Clinical update

Trial registry

3 studies